Activation of type 1 CRH receptor isoforms induces serotonin release from human carcinoid BON-1N cells: An enterochromaffin cell model

Endocrinology

Volumn 152, Issue 1, 2011, Pages 126-137

  Wu, S Vincent ^a   Yuan, Pu Qing ^a   Lai, Jim ^a   Wong, Kelvin ^a   Chen, Monica C ^a   Ohning, Gordon V ^a   Taché, Yvette ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING HORMONE RECEPTOR 1A; CORTICOTROPIN RELEASING HORMONE RECEPTOR 1C; CORTICOTROPIN RELEASING HORMONE RECEPTOR 1F; CORTICOTROPIN RELEASING HORMONE RECEPTOR 1I; CYCLIC AMP; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SEROTONIN; TRYPTOPHAN; TRYPTOPHAN HYDROXYLASE; UNCLASSIFIED DRUG; UROCORTIN I; UROCORTIN II;

ARTICLE; BRAIN CORTEX; CARCINOID; CELL FUNCTION; CELL LINE; CELL STRAIN HEK293; COLON; CONTROLLED STUDY; ENTEROCHROMAFFIN CELL; ENZYME PHOSPHORYLATION; ENZYME RELEASE; HUMAN; HUMAN CELL; HYPOPHYSIS; ILEUM; INTESTINE FUNCTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTONIN RELEASE; STRESS; SYNTHESIS; UPREGULATION;

CELL LINE, TUMOR; ENTEROCHROMAFFIN CELLS; GENE EXPRESSION REGULATION; HUMANS; MUTATION; PROTEIN ISOFORMS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RNA, MESSENGER; SEROTONIN; TRANSFECTION; TRYPTOPHAN HYDROXYLASE;

EID: 78650803795     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0997     Document Type: Article

References (57)

1. Gustafsson BI, Bakke I, Tømmerås K, Waldum HL 2006 A new method for visualization of gut mucosal cells, describing the entero-chromaffin cell in the rat gastrointestinal tract. Scand J Gastroen-terol 41:390-395
2. Bertrand PP, Bertrand RL 2010 Serotonin release and uptake in the gastrointestinal tract. Auton Neurosci 153:47-57
3. Costedio M M, Hyman N, Mawe G M 2007 Serotonin and its role in colonic function and in gastrointestinal disorders. Dis Colon Rectum 50:376-388
4. Nishiyama H, Mizuta Y, Isomoto H, Takeshima F, Omagari K, Miyahara Y, Murata I, Kohno S 2004 Chronic visceral hypersensi-tivity renders defecation more susceptible tostress via a serotonergic pathway in rats. Dig Dis Sci 49:763-769
5. Crowell MD, Shetzline MA, Moses PL, Mawe GM, Talley NJ 2004 Enterochromaffin cells and 5-HT signaling in the pathophysiology of disorders of gastrointestinal function. Curr Opin Investig Drugs 5:55-60
6. Hillhouse EW, Grammatopoulos DK 2006 The molecular mechanisms underlying the regulation of the biological activity of corti-cotropin-releasing hormone receptors: implications for physiology and pathophysiology. Endocr Rev 27:260-286
7. Tezval H, Jahn O, Todorovic C, Sasse A, Eckart K, Spiess J 2004 Cortagine, a specific agonist of corticotropin-releasing factor receptor subtype 1, is anxiogenic and antidepressive in the mouse model. Proc Natl Acad Sci USA 101:9468-9473
8. Rivier J, Gulyas J, Kunitake K, Di Gruccio M, Cantle JP, Perrin MH, Donaldson C, Vaughan J, Million M, Gourcerol G, Adelson DW, Rivier C, Taché Y, Vale W 2007 Stressin1-A, a potent corticotropin releasing factor receptor 1 (CRF1)-selective peptide agonist. J Med Chem 50:1668-1674
9. Stengel A, Taché Y 2009 Neuroendocrine control of the gut during stress: corticotropin-releasing factor signaling pathways in the spotlight. Annu Rev Physiol 71:219-239
10. 1 agonist, induces stresslike alterations of colonic function and visceral hypersensitivity in rodents primarily through peripheral pathways.Am J Physiol Gastrointest Liver Physiol 297:G215-G227
11. Wallon C, Yang PC, Keita AV, Ericson AC, McKay DM, Sherman PM, Perdue MH, Söderholm JD 2008 Corticotropin-releasing hormone (CRH) regulates macromolecular permeability via mast cells in normal human colonic biopsies in vitro. Gut 57:50-58
12. Wallon C, Soderholm JD 2009 Corticotropin-releasing hormone and mast cells in the regulation of mucosal barrier function in the human colon. Ann NY Acad Sci 1165:206-210
13. Fukudo S 2007 Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation. J Gastroenterol 42(Suppl 17):48-51
14. Ataka K, Kuge T, Fujino K, Takahashi T, Fujimiya M 2007 Wood creosote prevents CRF-induced motility via 5-HT3 receptors in proximal and 5-HT4 receptors in distal colon in rats. Auton Neu-rosci 133:136-145
15. Miyata K, Ito H, Fukudo S 1998 Involvement of the 5-HT3 receptor in CRH-induce defecation in rats. Am J Physiol 274:G827-G831
16. Nakade Y, Fukuda H, Iwa M, Tsukamoto K, Yanagi H, Yamamura T, Mantyh C, Pappas TN, Takahashi T 2007 Restraint stress stimulates colonic motility via central corticotropin-releasing factor and peripheral 5-HT3 receptors in conscious rats. Am J Physiol Gas-trointest Liver Physiol 292:G 1037-G 1044
17. Yuan PQ, Wu SV, Wang L, Tache Y 2010 Corticotropin releasing factor in the rat colon: expression, localization and upregulation by endotoxin. Peptides 31:322-331
18. Kawahito Y, Sano H, Mukai S, Asai K, Kimura S, Yamamura Y, Kato H, Chrousos GP, Wilder RL, Kondo M 1995 Corticotropin releasing hormone in colonic mucosa in patients with ulcerative colitis. Gut 37:544-551
19. Yuan PQ, Million M, Wu SV, Rivier J, Tache Y 2007 Peripheral corticotropin releasing factor (CRF) and a novel CRF1 receptor agonist, stressin1-A activate CRF1 receptor expressing cholinergic and nitrergic myenteric neurons selectively in the colon of conscious rats. Neurogastroenterol Motil 19:923-936
20. Schafermeyer A, Gratzl M, Rad R, Dossumbekova A, Sachs G, Prinz C 2004 Isolation and receptor profiling of ileal enterochromaffin cells. Acta Physiol Scand 182:53-62
21. Kidd M, Modlin IM, Eick GN, Champaneria MC 2006 Isolation, functional characterization, and transcriptome of Mastomys ileal enterochromaffin cells. Am J Physiol Gastrointest Liver Physiol 291: G778-G791 (Pubitemid 44772004)
22. Modlin IM, Kidd M, Pfragner R, Eick GN, Champaneria MC 2006 The functional characterization of normal and neoplastic human enterochromaffin cells. J Clin Endocrinol Metab 91:2340-2348 (Pubitemid 43855026)
23. Siddique ZL, Drozdov I, Floch J, Gustafsson BI, Stunes K, Pfragner R, Kidd M, Modlin IM 2009 KRJ-I and BON cell lines: defining an appropriate enterochromaffin cell neuroendocrine tumor model. Neuroendocrinology 89:458-470
24. Walther DJ, Peter JU, Bashammakh S, Hortnagl H, Voits M, Fink H, Bader M 2003 Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299:76
25. Markovic D, Vatish M, Gu M, Slater D, Newton R, Lehnert H, Grammatopoulos DK 2007 The onset of labor alters corticotropin-releasing hormone type 1 receptor variant expression in human myometrium: putative role of interleukin-1/3. Endocrinology 148: 3205-3213
26. Markovic D, Lehnert H, Levine MA, Grammatopoulos DK 2008 Structural determinants critical for localization and signaling within the seventh transmembrane domain of the type 1 corticotropin releasing hormone receptor: lessons from the receptor variant R1d. Mol Endocrinol 22:2505-2519
27. Zmijewski MA, Slominski AT 2010 Emerging role of alternative splicing of CRF1 receptor in CRF signaling. Acta Biochim Pol 57: 1-13
28. Zmijewski MA, Slominski AT 2009 CRF1 receptor splicing in epidermal keratinocytes: potential biological role and environmental regulations. J Cell Physiol 218:593-602
29. Wu SV, Yuan PQ, Wang L, Peng YL, Chen CY, Tache Y 2007 Identification and characterization of multiple corticotropin-releasing factor type 2 receptor isoforms in the rat esophagus. Endocrinology 148:1675-1687
30. Million M, Grigoriadis DE, Sullivan S, Crowe PD, McRoberts JA, Zhou H, Saunders PR, Maillot C, Mayer AE, Tache Y 2003 A novel water-soluble selective CRF1 receptor antagonist, NBI 35965, blunts stress-induced visceral hyperalgesia and colonic motor function in rats. Brain Research 985:32-42
31. Van Kolen K, Dautzenberg FM, Verstraeten K, Royaux I, De Hoogt R, Gutknecht E, Peeters PJ 2010 Corticotropin releasing factor-induced ERK phosphorylation in At T20 cells occurs via a cAMP-dependent mechanism requiring EPAC2. Neuropharmacology 58: 135-144
32. Hauger RL, Risbrough V, Brauns O, Dautzenberg FM 2006 Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets. CNS Neurol Disord Drug Targets 5:453-479
33. Stålberg P, Grimfjard P, Santesson M, Zhou Y, Lindberg D, Gobl A, Oberg K, Westin G, Rastad J, Wang S, Skogseid B 2004 Trans-fection of the multiple endocrine neoplasia type 1 gene to a human endocrine pancreatic tumor cell line inhibits cell growth and affects expression of Jun D, S-like protein 1/preadipocyte factor-1, proliferating cell nuclear antigen, and QM/Jif-1. J Clin Endocrinol Metab 89:2326-2337
34. Vitale G, de Herder WW, van Koetsveld PM, Waaijers M, Schoordijk W, Croze E, Colao A, Lamberts SW, Hofland LJ 2006IFN-/3 is a highly potent inhibitor of gastroenteropancreatic neuroendocrine tumor cell growth in vitro. Cancer Res 66:554-562
35. Parekh D, Ishizuka J, Townsend Jr CM, Haber B, Beauchamp RD, Karp G, Kim SW, Rajaraman S, Greeley Jr G, Thompson JC 1994 Characterization of a human pancreatic carcinoid in vitro: morphology, amine and peptide storage, and secretion. Pancreas 9:83-90
36. Kim M, Cooke HJ, Javed NH, Carey HV, Christofi F, Raybould H E 2001 D-glucose releases 5-hydroxytryptamine from human BON cells as a model of enterochromaffin cells. Gastroenterology 121: 1400-1406
37. Tran VS, Marion-Audibert AM, Karatekin E, Huet S, Cribier S, Guillaumie K, Chapuis C, Desnos C, Darchen F, Henry JP 2004 Serotonin secretion by human carcinoid BON cells. Ann NY Acad Sci 1014:179-188
38. Pisarchik A, Slominski A 2004 Molecular and functional characterization of novel CRFR1 isoforms from the skin. Eur J Biochem 271:2821-2830
39. Grammatopoulos DK, Dai Y, Randeva HS, Levine MA, Karteris E, Easton AJ, Hillhouse EW 1999 A novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes. Mol Endocrinol 13:2189-2202
40. Karteris E, Markovic D, Chen J, Hillhouse EW, Grammatopoulos DK 2010 Identification of a novel corticotropin-releasing hormone type 1/3-like teceptor variant lacking exon 13 in human pregnant myometrium regulated by estradiol-17/3 and progesterone. Endocrinology 151:4959-4968
41. Pisarchik A, Slominski AT 2001 Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression. FASEB J 15:2754-2756
42. Pisarchik A, Slominski A 2002 Corticotropin releasing factor receptor type 1: molecular cloning and investigation of alternative splicing in the hamster skin. J Invest Dermatol 118:1065-1072
43. Sullivan GM, Parsey RV, Kumar JS, Arango V, Kassir SA, Huang YY, Simpson NR, Van Heertum RL, Mann JJ 2007 PET Imaging of CRF1 with [11C]R 121920 and [11C]DMP696: is the target of sufficient density? Nucl Med Biol 34:353-361
44. Porcher C, Juhem A, Peinnequin A, Sinniger V, Bonaz B 2005 Expression and effects of metabotropic CRF1 and CRF2 receptors in rat small intestine. Am J Physiol 288:G 1091-G 1103
45. Kishore S, Khanna A, Zhang Z, Hui J, Balwierz PJ, Stefan M, Beach C, Nicholls RD, Zavolan M, Stamm S 2010 The snoRNA MBII-52 (SNORD 115) is processed into smaller RNAs and regulates alternative splicing. Hum Mol Genet 19:1153-1164
46. Kishore S, Stamm S 2006 Thesno RNA HBII-52 regulates alternative splicing of the serotonin receptor 2C. Science 311:230-232
47. Young SF, Griffante C, Aguilera G 2007 Dimerization between va-sopressin V1b and corticotropin releasing hormonetype1receptors. Cell Mol Neurobiol 27:439-461
48. Mikhailova MV, Blansett J, Jacobi S, Mayeux PR, Cornett L E 2008 Transmembrane domain IV of the Gallus gallus VT2 vasotocin receptor is essential for forming aheterodimer with the corticotrophin releasing hormone receptor. J Biomed Opt 13:031208
49. Linde L, Boelz S, Nissim-Rafinia M, Oren YS, Wilschanski M, Yaacov Y, Virgilis D, Neu-Yilik G, Kulozik AE, Kerem E, Kerem B 2007 Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin. J Clin Invest 117:683-692
50. Ressler KJ, Bradley B, Mercer KB, Deveau TC, Smith AK, Gillespie CF, Nemeroff CB, Cubells JF, Binder EB 2010 Polymorphisms in CRHR1 and the serotonin transporter loci: gene x gene x environment interactions ondepressive symptoms.Am JMed Genet B Neu-ropsychiatr Genet 153B:812-824
51. Wasserman D, Wasserman J, Rozanov V, Sokolowski M 2009 Depression in suicidal males: genetic risk variants in the CRHR1 gene. Genes Brain Behav 8:72-79
52. Dautzenberg FM, Higelin J, Teichert U 2000 Functional characterization of corticotropin-releasing factor type 1 receptor endog-enously expressedin human embryonic kidney 293 cells. Eur J Pharmacol 390:51-59
53. Hoare SR, Sullivan SK, Ling N, Crowe PD, Grigoriadis DE 2003 Mechanism of corticotropin-releasing factor type I receptor regulation by nonpeptide antagonists. Mol Pharmacol 63:751-765
54. von Mentzer B, Murata Y, Ahlstedt I, Lindström E, Martínez V 2007 Functional CRF receptors in BON cells stimulate serotonin release. Biochem Pharmacol 73:805-813
55. Martinez V, Taché Y 2006 CRF1 receptors as a therapeutic target for irritable bowel syndrome. Curr Pharm Des 12:4071-4088
56. Hirata T, Keto Y, Nakata M, Takeuchi A, Funatsu T, Akuzawa S, Sasamata M, Miyata K 2008 Effects of serotonin 5-HT(3) receptor antagonists on CRF-induced abnormal colonic water transport and defecation in rats. Eur J Pharmacol 587:281-284
57. Kawahito Y, Sano H, Kawata M, Yuri K, Mukai S, Yamamura Y, Kato H, Chrousos GP, Wilder RL, Kondo M 1994 Local secretion of corticotropin-releasing hormone by enterochromaffin cells in human colon. Gastroenterology 106:859-865